WALGREEN CO (NYSE: WAG)





$33.61 0.32 (0.96%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
40.69
52-Week Low Price
21.39
Avg Volume (3 Mo.)
8.00 M
Market Cap
32.80 B
P/E Ratio (TTM)
15.8
Diluted EPS (TTM)
2.32
Shares
985.17 M
Dividend Rate ($) / (%)
0.55/1.70
94%
6%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 22% - WAG has underperformed the S&P 500 by 4%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
CVS CAREMARK CORP (CVS) $32.72 -  $0.00(0.00%)43.83 B
SALLY BEAUTY HOLDINGS;... (SBH) $8.04 -  $0.13(1.64%)1.45 B
CHINA NEPSTAR CHAIN ADS (NPD) $6.51 -  $0.19(3.01%)1.31 B
RITE AID CORP (RAD) $1.31 -  $0.02(1.55%)1.16 B
PHARMERICA CORP (PMC) $16.55 -  $0.05(0.30%)0.50 B
DRUGSTORE.COM INC (DSCM) $2.75 -  $0.00(0.00%)0.29 B
PERFUMANIA HOLDINGS INC (PERF) $7.00 -  $0.30(4.48%)0.06 B
LIBERATOR MEDICAL HLDGS (LBMH) $2.00 -  $0.21(11.73%)0.06 B
VITAVEA INC (VVEA) $0.00 -  $0.00(0.00%)0.03 B
MY HEALTHY ACCESS; INC... (MYHA) $0.01 -  $0.00(0.00%)0.03 B
STOCK ANALYSIS
Stock Analysis
Walgreens Gets A Strong Dose Of Profits (WAG, CVS, RAD, WMT, TGT)
The company had an outstanding quarter, thanks in part to the arrival of an early flu season.
Stock Analysis
Walgreens Suffers The Retailing Curse (WAG, WMT, CVS, RAD)
While Wal-Greens report is simply a monthly tally, the next earnings release may follow suit and disappoint analysts.
Stock Analysis
This Week's Activist Filings (TGT, WAG, RAD, GST, CDR)
Activist filings taken from SEC documents November 5-11 reveal that investors continue to push for value seeking ch...
Stock Analysis
Walgreen Serves Up Some Good Medicine (WAG, CVS, RAD, WMT)
This company's better-than-expected Q4 results drew some attention, and it may be deserved.
Stock Analysis
Rite Aid Continues Its Losing Ways (RAD, WAG, CVS, SHLD, COST)
Rite Aid posted another losing quarter last week, and is still woefully behind its two main competitors, Walgreen a...
WAG RELATED HEADLINES
arrow
Generic Drugs Could Boost Pharmacies
With some best-sellers due to go off-patent in coming years, generics could turn more profitable for the likes of CVS, Walgreen and Rite-Aid.

Forbes.com 2/8/2010
arrow
CVS Caremark Clears Street's Hurdle
Fourth-quarter earnings beat helps drugstore chain outpace its retail rivals.

Forbes.com 2/8/2010
arrow
Bears Capitalize on Walgreen Company's Dismal Sales Report
Following a disappointing January sales report this morning, drugstore chain Walgreen Company (WAG: sentiment, chart, options) has seen a flurry of option activity...(Read More)

By SchaeffersResearch 2/3/2010
arrow
Stocks Stumble, Tech Shines
Markets pull back after two days of gains but technology investors stay bullish. Cisco makes case for strong recovery.

Forbes.com 2/3/2010
arrow
Generics, Feeble Flu Weigh On Walgreen Sales
Same-store sales down 1.1% as the retail pharmacy chain tries to entice cost-conscious shoppers.

Forbes.com 2/3/2010
arrow
Walgreen (WAG) NewsBite - WAG January Sales Disappoint
Walgreen (NYSE: WAG) opened at $36.00. So far today, the stock has hit a low of $35.35 and a high of $36.19. WAG is now trading at $35.52, down $1.26 (-3.43%). Over the last 52 weeks the stock has ranged from a low of $21.39 to a high of $40.69. Shares of WAG are trading lower this morning after the company said its same-store sales fell 1.1 percent in January. Analysts were expecting th...

At Market Intelligence Center 2/3/2010
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1